Specialty
Wound Care devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
609
510(k), De Novo and PMA
Decisions, last 36 months
170
Recruiting device trials
178
Industry sponsored
Adverse event reports
9,157
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
K262232 · Decided Nov 6, 2026 · 129 days after receipt
Device type: Negative Pressure Wound Therapy Powered Suction Pump (OMP) · General & Plastic Surgery
Smith and Nephew Medical Limited
K263567 · Decided Nov 6, 2026 · 37 days after receipt
Device type: Negative Pressure Wound Therapy Device For Reduction Of Wound Complications (QFC) · General & Plastic Surgery
- Kerecis Express (50250)510(k)
K260058 · Decided Oct 30, 2026 · 295 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K260306 · Decided Oct 30, 2026 · 273 days after receipt
Device type: Negative Pressure Wound Therapy Powered Suction Pump (OMP) · General & Plastic Surgery
- Triad Hydrophilic Wound Dresssing (1964, 2.5 oz); Triad Hydrophilic Wound Dressing (1967, 6 oz)510(k)
K260285 · Decided Oct 26, 2026 · 270 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
K261982 · Decided Oct 23, 2026 · 133 days after receipt
Device type: Negative Pressure Wound Therapy Powered Suction Pump (OMP) · General & Plastic Surgery
Berkeley Advanced Biomaterials
K260920 · Decided Oct 22, 2026 · 217 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
- Restrata510(k)
K261245 · Decided Oct 16, 2026 · 183 days after receipt
Device type: Absorbable Synthetic Wound Dressing (QSZ) · General & Plastic Surgery
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 8 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 |
| Feb 24 | 3 | 0 | 0 |
| Mar 24 | 6 | 1 | 0 |
| Apr 24 | 6 | 0 | 0 |
| May 24 | 7 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 |
| Jul 24 | 11 | 0 | 0 |
| Aug 24 | 7 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 |
| Oct 24 | 7 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 |
| Dec 24 | 5 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 |
| Mar 25 | 5 | 0 | 0 |
| Apr 25 | 2 | 0 | 0 |
| May 25 | 2 | 0 | 0 |
| Jun 25 | 5 | 0 | 0 |
| Jul 25 | 2 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 |
| Oct 25 | 5 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 |
| Dec 25 | 6 | 0 | 1 |
| Jan 26 | 6 | 0 | 0 |
| Feb 26 | 6 | 1 | 0 |
| Mar 26 | 5 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 |
| May 26 | 5 | 1 | 0 |
| Jun 26 | 11 | 0 | 1 |
| Jul 26 | 1 | 0 | 0 |
| Aug 26 | 5 | 0 | 0 |
| Sep 26 | 7 | 0 | 0 |
| Oct 26 | 8 | 0 | 0 |
| Nov 26 | 2 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring FracturesRecruiting
SI-BONE, Inc.Public (SIBN)
NCT07530497 · 120 participants (planned) · Start Aug 24, 2026 · Primary completion Feb 2028
Device: iFuse TORQ TNT Implant System · For: Fracture; Pelvic; Insufficiency Fractures; Fragility Fracture and 3 more
Sites: Los Angeles, California; Edina, Minnesota; Rochester, Minnesota · 4 sites in all
Artoss Inc.Not on our public-company list
NCT06256458 · 200 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 1, 2026
Device: NanoBone® Bone Graft · For: Fractures, Bone
Sites: Madison, Wisconsin
- Silica-Based Wound Treatment (Curi01) Plus Standard Care Versus Standard Care Alone for Chronic Diabetic Foot WoundsPivotal-lookingRecruiting
Cutempa Medical AGNot on our public-company list
NCT07937215 · 280 participants (planned) · Start Aug 20, 2026 · Primary completion Feb 2028
Device: Curi01 · For: Diabetic Foot Disease; Foot Ulcer Due to Type 1 Diabetes Mellitus; Foot Ulcer Due to Type 2 Diabetes Mellitus
Sites: Bad Mergentheim, Germany; Berlin, Germany; Bremerhaven, Germany · 13 sites in all
Aesculap AGNot on our public-company list
NCT05966961 · 2,998 participants (planned) · Start Sep 18, 2023 · Primary completion Aug 2028
Device: Novosyn® in emergency or elective laparotomy or laparoscopic surgery; Polyglactin 910 in emergency or elective laparotomy or laparoscopic surgery · For: Surgical Site Infection
Sites: Bari, Italy; Castel Volturno, Italy; Lavagna, Italy · 11 sites in all
Neuralink CorpNot on our public-company list
NCT07929792 · 10 participants (planned) · Start Nov 2026 · Primary completion Nov 2027
Device: N1 Implant; R1 Robot · For: Spinal Cord Injury; Amyotrophic Lateral Sclerosis; Chronic Ischemic Stroke and 1 more
Sites: Miami, Florida
Neuralink CorpNot on our public-company list
NCT07224256 · 6 participants (planned) · Start Oct 3, 2025 · Primary completion Oct 2028
Device: N1 Implant; R1 Robot · For: Tetraplegia/Tetraparesis; Quadriplegia; Cervical Spinal Cord Injury and 4 more
Sites: Dallas, Texas
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
9,157
Received Nov 1, 2025 to Nov 19, 2026. Includes 30 of another or unstated type.
Malfunction reports
8,085
88% of reports
Injury reports
1,026
11% of reports
Death reports
16
0.2% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 362 | 93 | 1 | 1 |
| Dec 25 | 238 | 72 | 1 | 0 |
| Jan 26 | 344 | 41 | 1 | 0 |
| Feb 26 | 140 | 65 | 1 | 0 |
| Mar 26 | 161 | 89 | 0 | 1 |
| Apr 26 | 301 | 150 | 1 | 0 |
| May 26 | 179 | 119 | 1 | 0 |
| Jun 26 | 136 | 76 | 1 | 0 |
| Jul 26 | 922 | 76 | 1 | 0 |
| Aug 26 | 3,261 | 74 | 4 | 5 |
| Sep 26 | 1,808 | 70 | 1 | 11 |
| Oct 26 | 233 | 101 | 3 | 12 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0081-2027 · Started Sep 2, 2026 · Posted by FDA Oct 2, 2026
Reason given: Compression bandage may be degraded, which may cause unwanted foreign material to be introduced inside the wound, which may lead to wound exploration and irrigation, formation of scar tissue, and infection.
Cause as FDA categorized it: Component change control · Device type: Dressing, Compression (MHW)
Z-3177-2026 · Started Aug 20, 2026 · Posted by FDA Sep 16, 2026
Reason given: Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).
Cause as FDA categorized it: Labeling design · Device type: Hemostatic Device For Endoscopic Gastrointestinal Use (QAU)
- Medline Convenience Kits: 1) DYNDH1193, Catalog Number: DYNDH1193; 2) DYNDH1487A, Catalog Number: DYNDH1487AOpen, Classified
Z-3126-2026 · Started Aug 11, 2026 · Posted by FDA Sep 14, 2026
Reason given: The kits contain certain lots of sterile applicators which may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides. Contamination of skin preparation products with Aspergillus penicillioides may lead to serious adverse health...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Wound Dressing Kit (MCY)
- Medline Convenience Kits containing BD ChloraPrep Clear - 1mL Applicators BLOOD CULTURE KIT 2 W/CONNECT DYNDH1487AOpen, Classified
Z-3072-2026 · Started Jul 20, 2026 · Posted by FDA Aug 31, 2026
Reason given: Downstream recall - manufacturer recalled specific lots of BD ChloraPrep Clear - 1mL Applicators. Affected product may exhibit an open or incomplete seal on the packaging of the applicator. Use of potentially contaminated applicator may lead to localized skin or soft tissue infection, or systemic infection or...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Wound Dressing Kit (MCY)
- SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.Open, Classified
Z-2775-2026 · Started Jun 30, 2026 · Posted by FDA Jul 22, 2026
Reason given: The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/...
Cause as FDA categorized it: Software design · Device type: Autofluorescence Imaging Adjunct Tool For Wounds (QJF)
- Medline Convenience Kits: 1) BLOOD CULTURE TRAY PEDIATRIC, Model Number: DYNDH1193; 2) BLOOD CULTURE KIT 2 W/CONNECT, Model Number: DYNDH1487AOpen, Classified
Z-3057-2026 · Started Jun 12, 2026 · Posted by FDA Aug 31, 2026
Reason given: The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination....
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Wound Dressing Kit (MCY)
Z-2677-2026 · Started Jun 8, 2026 · Posted by FDA Jul 7, 2026
Reason given: Surgical dressing manufactured out of specification (greater thickness).
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Dressing, Wound, Drug (FRO)
- DeRoyal Industries Inc. Ref 46-406, Covaderm Plus, Vascular Access Dressing 6"x6" (15cmx15cm)Open, Classified
Z-2305-2026 · Started May 18, 2026 · Posted by FDA Jun 3, 2026
Reason given: Sterile wound dressing, lacks sterility assurance
Cause as FDA categorized it: Under Investigation by firm · Device type: Dressing, Wound, Hydrophilic (NAC)
Showing the 8 newest of 494 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.